{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,21]],"date-time":"2026-05-21T06:45:16Z","timestamp":1779345916683,"version":"3.51.4"},"reference-count":43,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T00:00:00Z","timestamp":1673222400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","award":["319282"],"award-info":[{"award-number":["319282"]}],"id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Healthcare"],"abstract":"<jats:p>Background: Risk factors for developing long COVID are not clearly established. The present study was designed to determine if any sign, symptom, or treatment of the acute phase, or personal characteristics of the patient, is associated with the development of long COVID. Methods: A cohort study was carried out, randomly selecting symptomatic COVID-19 patients and not vaccinated. The severity of the acute illness was assessed through the number of compatible COVID-19 symptoms, hospitalizations, and the symptom severity score using a 10-point visual analog scale. Results: After multivariate analysis, a severity score \u22658 (RR 2.0, 95%CI 1.1\u20133.5, p = 0.022), hospitalization (RR 2.1, 95%CI 1.0\u20134.4, p = 0.039), myalgia (RR 1.9, 95%CI 1.08\u20133.6, p = 0.027), tachycardia (RR 10.4, 95%CI 2.2\u201347.7, p = 0.003), and use of antibiotics (RR 2.0, 95%CI 1.1\u20133.5, p = 0.022), was positively associated with the risk of having long COVID. Higher levels of education (RR 0.6, 95%CI 0.4\u20130.9, p = 0.029) and type positive B blood group (B + AB, RR 0.44, 95%CI 0.2\u20130.9, p = 0.044) were protective factors. The most important population attributable fractions (PAFs) for long COVID were myalgia (37%), severity score \u22658 (31%), and use of antibiotics (27%). Conclusions: Further studies in diverse populations over time are needed to expand the knowledge that could lead us to prevent and\/or treat long COVID.<\/jats:p>","DOI":"10.3390\/healthcare11020197","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T03:25:58Z","timestamp":1673234758000},"page":"197","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":28,"title":["Clinical Characteristics in the Acute Phase of COVID-19 That Predict Long COVID: Tachycardia, Myalgias, Severity, and Use of Antibiotics as Main Risk Factors, While Education and Blood Group B Are Protective"],"prefix":"10.3390","volume":"11","author":[{"given":"Jose","family":"Guzman-Esquivel","sequence":"first","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"},{"name":"Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de \u00c1lvarez 28984, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7646-0842","authenticated-orcid":false,"given":"Martha A.","family":"Mendoza-Hernandez","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"},{"name":"Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de \u00c1lvarez 28984, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hannah P.","family":"Guzman-Solorzano","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karla A.","family":"Sarmiento-Hernandez","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5988-4168","authenticated-orcid":false,"given":"Iram P.","family":"Rodriguez-Sanchez","sequence":"additional","affiliation":[{"name":"Molecular and Structural Physiology Laboratory, School of Biological Sciences, Universidad Aut\u00f3noma de Nuevo Le\u00f3n, San Nicol\u00e1s de los Garza 66455, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1478-9068","authenticated-orcid":false,"given":"Margarita L.","family":"Martinez-Fierro","sequence":"additional","affiliation":[{"name":"Molecular Medicine Laboratory, Unidad de Medicina Humana y Ciencias de la Salud, Universidad Aut\u00f3noma de Zacatecas, Zacatecas 98160, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-6505","authenticated-orcid":false,"given":"Brenda A.","family":"Paz-Michel","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"},{"name":"Department of Research, Esteripharma SA de CV, Atlacomulco 50450, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1118-498X","authenticated-orcid":false,"given":"Efren","family":"Murillo-Zamora","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"},{"name":"Clinical Epidemiology Research Unit, Mexican Institute of Social Security Institute, Villa de \u00c1lvarez 28984, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1744-9173","authenticated-orcid":false,"given":"Fabian","family":"Rojas-Larios","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angel","family":"Lugo-Trampe","sequence":"additional","affiliation":[{"name":"Faculty of Human Medicine, Campus IV, Universidad Aut\u00f3noma de Chiapas, Tapachula 30580, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge E.","family":"Plata-Florenzano","sequence":"additional","affiliation":[{"name":"Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Delgado-Machuca","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9848-862X","authenticated-orcid":false,"given":"Ivan","family":"Delgado-Enciso","sequence":"additional","affiliation":[{"name":"School of Medicine, University of Colima, Colima 28040, Mexico"},{"name":"Cancerology State Institute, Colima State Health Services, Colima 28085, Mexico"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,9]]},"reference":[{"key":"ref_1","unstructured":"Cascella, M., Rajnik, M., Cuomo, A., Dulebohn, S.C., and Di Napoli, R. (2020). Features, Evaluation and Treatment Coronavirus (COVID-19). Treasure Island (FL), StatPearls Publishing."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.3389\/fpubh.2020.00337","article-title":"The Coronavirus Disease (COVID-19) Challenge in Mexico: A Critical and Forced Reflection as Individuals and Society","volume":"8","year":"2020","journal-title":"Front. Public Heal."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"915","DOI":"10.3892\/etm.2021.10347","article-title":"Safety and Efficacy of a COVID-19 Treatment with Nebulized and\/or Intravenous Neutral Electrolyzed Saline Combined with Usual Medical Care vs. Usual Medical Care Alone: A Randomized, Open-label, Controlled Trial","volume":"22","year":"2021","journal-title":"Exp. Ther. Med."},{"key":"ref_4","doi-asserted-by":"crossref","unstructured":"Abdelhafiz, A.S., Ali, A., Maaly, A.M., Mahgoub, M.A., Ziady, H.H., and Sultan, E.A. (2022). Predictors of Post-COVID Symptoms in Egyptian Patients: Drugs Used in COVID-19 Treatment Are Incriminated. PLoS ONE, 17.","DOI":"10.1371\/journal.pone.0266175"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1001\/jamainternmed.2022.4299","article-title":"COVID-19-Associated Hospitalizations Among Vaccinated and Unvaccinated Adults 18 Years or Older in 13 US States, January 2021 to April 2022","volume":"182","author":"Havers","year":"2022","journal-title":"JAMA Intern. Med."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"e1018","DOI":"10.1016\/S2214-109X(20)30285-0","article-title":"Ethnic and Regional Variations in Hospital Mortality from COVID-19 in Brazil: A Cross-Sectional Observational Study","volume":"8","author":"Baqui","year":"2020","journal-title":"Lancet Glob. Heal."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e06008","DOI":"10.1016\/j.heliyon.2021.e06008","article-title":"Kidney Diseases and COVID-19 Infection: Causes and Effect, Supportive Therapeutics and Nutritional Perspectives","volume":"7","author":"Askari","year":"2021","journal-title":"Heliyon"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"12567","DOI":"10.1038\/s41598-020-68862-x","article-title":"COVID-19 Mortality Is Negatively Associated with Test Number and Government Effectiveness","volume":"10","author":"Liang","year":"2020","journal-title":"Sci. Rep."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"993","DOI":"10.15585\/mmwr.mm6930e1","article-title":"Symptom Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network\u2014United States, March\u2013June 2020","volume":"69","author":"Tenforde","year":"2020","journal-title":"MMWR. Morb. Mortal. Wkly. Rep."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1093\/infdis\/jiac136","article-title":"Global Prevalence of Post COVID-19 Condition or Long COVID: A Meta-Analysis and Systematic Review","volume":"226","author":"Chen","year":"2022","journal-title":"J. Infect. Dis."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"16144","DOI":"10.1038\/s41598-021-95565-8","article-title":"More than 50 Long-Term Effects of COVID-19: A Systematic Review and Meta-Analysis","volume":"11","author":"Perelman","year":"2021","journal-title":"Sci. Rep."},{"key":"ref_12","first-page":"20499361211069264","article-title":"Symptom Cluster Analysis of Long COVID-19 in Patients Discharged from the Temporary COVID-19 Hospital in Mexico City","volume":"9","author":"Bello","year":"2022","journal-title":"Ther. Adv. Infect. Dis."},{"key":"ref_13","first-page":"428","article-title":"Risk Factors Associated with Long COVID Syndrome: A Retrospective Study","volume":"46","author":"Akbari","year":"2021","journal-title":"Iran. J. Med. Sci."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"n1648","DOI":"10.1136\/bmj.n1648","article-title":"Long Covid-Mechanisms, Risk Factors, and Management","volume":"374","author":"Crook","year":"2021","journal-title":"BMJ"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1038\/s41591-022-01909-w","article-title":"Symptoms and Risk Factors for Long COVID in Non-Hospitalized Adults","volume":"28","author":"Subramanian","year":"2022","journal-title":"Nat. Med."},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"(2021). Rana R, Ranjan V and Kumar N: Association of ABO and Rh Blood Group in Susceptibility, Severity, and Mortality of Coronavirus Disease 2019: A Hospital-Based Study from Delhi, India. Front. Cell. Infect. Microbiol, 11, 767771.","DOI":"10.3389\/fcimb.2021.767771"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e58728","DOI":"10.7554\/eLife.58728","article-title":"Screening of Healthcare Workers for SARS-CoV-2 Highlights the Role of Asymptomatic Carriage in COVID-19 Transmission","volume":"9","author":"Rivett","year":"2020","journal-title":"eLife"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/01.ASW.0000721168.40561.a3","article-title":"Validity of the Fitzpatrick Skin Phototype Classification in Ecuador","volume":"33","author":"Fors","year":"2020","journal-title":"Adv. Skin Wound Care"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"623","DOI":"10.7326\/M20-4207","article-title":"Hydroxychloroquine in Nonhospitalized Adults With Early COVID-19","volume":"173","author":"Skipper","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1093\/aje\/kwg074","article-title":"Estimating the Relative Risk in Cohort Studies and Clinical Trials of Common Outcomes","volume":"157","author":"McNutt","year":"2003","journal-title":"Am. J. Epidemiol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1093\/oxfordjournals.aje.a114212","article-title":"Binomial Regression in GLIM: Estimating Risk Ratios and Risk Differences","volume":"123","author":"Wacholder","year":"1986","journal-title":"Am. J. Epidemiol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Diaz-Quijano, F.A. (2012). A Simple Method for Estimating Relative Risk Using Logistic Regression. BMC Med. Res. Methodol., 12.","DOI":"10.1186\/1471-2288-12-14"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"k757","DOI":"10.1136\/bmj.k757","article-title":"Population Attributable Fraction","volume":"360","author":"Mansournia","year":"2018","journal-title":"BMJ"},{"key":"ref_24","unstructured":"Bernard, R. (2000). Fundamentals of Biostatistics, PWS Publishing. [5th ed.]."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1136\/bmj.329.7459.209","article-title":"Ruling a Diagnosis in or out with \u201cSpPIn\u201d and \u201cSnNOut\u201d: A Note of Caution","volume":"329","author":"Pewsner","year":"2004","journal-title":"BMJ"},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study","volume":"395","author":"Chen","year":"2020","journal-title":"Lancet"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"20503121211054972","DOI":"10.1177\/20503121211054973","article-title":"The Clinical Implications of Sinus Tachycardia in Mild COVID-19 Infection: A Retrospective Cohort Study","volume":"9","author":"Hsieh","year":"2021","journal-title":"SAGE Open Med."},{"key":"ref_28","doi-asserted-by":"crossref","unstructured":"Denegri, A., Sola, M., Morelli, M., Farioli, F., Alberto, T., D\u2019Arienzo, M., Savorani, F., Pezzuto, G.S., Boriani, G., and Szarpak, L. (2022). Arrhythmias in COVID-19\/SARS-CoV-2 Pneumonia Infection: Prevalence and Implication for Outcomes. J. Clin. Med., 11.","DOI":"10.3390\/jcm11051463"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/s41598-021-03831-6","article-title":"Inappropriate Sinus Tachycardia in Post-COVID-19 Syndrome","volume":"12","author":"Bazan","year":"2022","journal-title":"Sci. Rep."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1007\/s10067-020-05178-1","article-title":"Can COVID-19 Cause Myalgia with a Completely Different Mechanism? A Hypothesis","volume":"39","author":"Kucuk","year":"2020","journal-title":"Clin. Rheumatol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"419","DOI":"10.3389\/fncel.2017.00419","article-title":"Peripheral Mechanisms of Ischemic Myalgia","volume":"11","author":"Queme","year":"2017","journal-title":"Front. Cell. Neurosci."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/gutjnl-2021-325989","article-title":"Gut Microbiota Dynamics in a Prospective Cohort of Patients with Post-Acute COVID-19 Syndrome","volume":"71","author":"Liu","year":"2022","journal-title":"Gut"},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Nguyen, Q.V., Chong, L.C., Hor, Y.-Y., Lew, L.-C., Rather, I.A., and Choi, S.-B. (2022). Role of Probiotics in the Management of COVID-19: A Computational Perspective. Nutrients, 14.","DOI":"10.3390\/nu14020274"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"101624","DOI":"10.1016\/j.eclinm.2022.101624","article-title":"Impact of COVID-19 Vaccination on the Risk of Developing Long-COVID and on Existing Long-COVID Symptoms: A Systematic Review","volume":"53","author":"Notarte","year":"2022","journal-title":"EClinicalMedicine"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/j.semvascsurg.2021.05.005","article-title":"Relationship between Blood Type and Outcomes Following COVID-19 Infection","volume":"34","author":"Kim","year":"2021","journal-title":"Semin. Vasc. Surg."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1080\/23744235.2022.2115548","article-title":"Blood Group O Is Associated with Post-COVID-19 Syndrome in Outpatients with a Low Comorbidity Index","volume":"54","author":"Navas","year":"2022","journal-title":"Infect. Dis."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00277-020-04169-1","article-title":"Blood Type and Outcomes in Patients with COVID-19","volume":"99","author":"Latz","year":"2020","journal-title":"Ann. Hematol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/trf.17170","article-title":"A Large Cohort Study of the Effects of Lewis, ABO, 13 Other Blood Groups and Secretor Status on COVID-19 Susceptibility, Severity, and Long COVID-19","volume":"63","author":"Moslemi","year":"2023","journal-title":"Transfusion"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple Early Factors Anticipate Post-Acute COVID-19 Sequelae","volume":"185","author":"Su","year":"2022","journal-title":"Cell"},{"key":"ref_41","first-page":"e112681","article-title":"Prevalence of Anti-SARS-CoV-2 Antibody in Hospital Staff in Double-Center Setting: A Preliminary Report of a Cohort Study From Iran","volume":"22","author":"Honarvar","year":"2021","journal-title":"Shiraz E-Med. J."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"e121681","DOI":"10.5812\/semj-121681","article-title":"SARS-CoV-2 Antibodies in the Public Hospital Staff: The Second Report of a Seroprevalence Cohort Study from Iran","volume":"23","author":"Amanat","year":"2022","journal-title":"Shiraz E-Med. J."},{"key":"ref_43","first-page":"4","article-title":"Acute and Long-term Psychiatric Symptoms Associated with COVID-19 (Review)","volume":"18","year":"2023","journal-title":"Biomed. Rep."}],"container-title":["Healthcare"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/2\/197\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:55Z","timestamp":1760119435000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9032\/11\/2\/197"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,9]]},"references-count":43,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["healthcare11020197"],"URL":"https:\/\/doi.org\/10.3390\/healthcare11020197","relation":{},"ISSN":["2227-9032"],"issn-type":[{"value":"2227-9032","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,9]]}}}